News

Home/News
News 2017-06-21T13:15:59+00:00
March 27, 2018
BioTime Announces Cash Sale of Ascendance Biotechnology
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that IVT Holdings acquired Ascendance Biotechnology, Inc. BioTime’s ...
March 27, 2018
Arrowhead Begins Dosing in Phase 1/2 Study of ARO-HBV for Treatment of Chronic Hepatitis B
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it has dosed the first subjects in a Phase 1/2 clinical study of ARO-HBV, which is ...
March 27, 2018
Tyme Announces First Site Open for its Phase II Trial with SM-88 in Pancreatic Cancer
NEW YORK, March 27, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME) (“Tyme” or the “Company”) announced today that the first site for the Phase II ...
March 27, 2018
Pernix Therapeutics Announces Return to Market of Zohydro® ER with BeadTek® 20 mg
MORRISTOWN, N.J., March 27, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical company, today announced that it expects to resume distribution ...
March 27, 2018
HTG Molecular Diagnostics Secures Debt Facility with MidCap Financial
TUCSON, Ariz., March 27, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications ...
March 27, 2018
Altimmune Announces Positive Data From Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine and Provides an Update on Its Phase 1b Study of HepTcell Targeted Immunotherapy in Chronic Hepatitis B Infection
GAITHERSBURG, Md., March 27, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced positive data from its Phase 2a study of ...
March 27, 2018
STRATA Skin Sciences, Inc. to Report Fiscal 2017 Financial Results on Thursday, March 29
HORSHAM, Pa., March 27, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to ...
March 27, 2018
Krystal Submits Investigational New Drug (IND) Application for KB103, Topical Gene Therapy Candidate for Dystrophic Epidermolysis Bullosa
PITTSBURGH, March 27, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (KRYS), a gene therapy company developing “off-the-shelf” treatments for rare dermatological diseases, announces the ...
March 27, 2018
Caelum Biosciences Announces Updated Phase 1b Data Presented at 16th International Symposium on Amyloidosis
NEW YORK, March 27, 2018 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. (FBIO) Company developing treatments for rare and life-threatening diseases, ...
March 27, 2018
Oncobiologics Appoints Dr. Joerg Windisch to Board of Directors
CRANBURY, N.J., March 27, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (ONS) today announced the appointment of Joerg Windisch, Ph.D. to its board of directors, effective ...
March 26, 2018
Prometic to report its Fourth Quarter and Year-End 2017 Financial Results and hold Conference Call / Webcast
LAVAL, QC, March 26, 2018 /PRNewswire/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) ("Prometic") announced today that it will report its financial results for the fourth ...
March 26, 2018
Heat Biologics Reports Positive Data to Further Support the Mechanism of Action for its Proprietary T-Cell Activation Platform
DURHAM, NC / ACCESSWIRE / March 26, 2018 / Heat Biologics, Inc. (HTBX), a biopharmaceutical company developing drugs designed to activate a patient's immune system ...
March 26, 2018
Intec Pharma Appoints Roger J. Pomerantz, M.D. to Board of Directors
JERUSALEM, March 26, 2018 /PRNewswire/ -- Intec Pharma LTD (NASDAQ, TASE: NTEC) ("Intec" or "the Company") today announces the appointment of Roger J. Pomerantz, M.D., F.A.C.P. ...
March 26, 2018
Catalyst Biosciences Receives $1.5 Million In Two Milestone Payments for Neuronal Nicotinic Receptor (NNR) Asset
SOUTH SAN FRANCISCO, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
March 26, 2018
Eiger Announces First Patient Dosed in Phase 2 PREVENT Study of Exendin 9-39 in Patients Suffering from Post-Bariatric Hypoglycemia
PALO ALTO, Calif., March 26, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of therapies for rare diseases, today announced the ...
March 26, 2018
ARMO BioSciences Announces Positive Outcome of First Interim Analysis in SEQUOIA Phase 3 Pancreatic Cancer Study
REDWOOD CITY, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- ARMO BioSciences, Inc. (ARMO), a late-stage immuno-oncology company, today announced the completion of the first interim ...
March 26, 2018
Palatin Technologies Announces Submission of Bremelanotide NDA to FDA for Treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
CRANBURY, N.J., March 26, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases ...
March 26, 2018
BioLife Solutions and SAVSU Technologies to be Awarded Second Patent for Next Generation Cold Chain Technologies Designed for Cell and Gene Therapies
BOTHELL, Wash. and ALBUQUERQUE, N.M., March 26, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue ...
March 26, 2018
Aeglea BioTherapeutics Appoints Dr. Ivana Magovčević-Liebisch to Board of Directors
AUSTIN, Texas, March 26, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
March 26, 2018
Advaxis Announces Four Poster Presentations Highlighting Lm-based Antigen Delivery Technology at AACR 2018
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced that results from multiple preclinical ...
Page 8 of 70